跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ENALAPRIL TABLET 20 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ENALAPRIL TABLET 20 MG
Approved
THERAPEUTIC
APO-ENALAPRIL TABLET 20 MG
APOTEX INC - CANADAPROTEIN SA DE C V (MEXICO)
🇸🇬 Health Sciences Authority
Approval Date
Aug 6, 1996
Approval ID
2e859f0fa96ce185
Company
APOTEX INC - CANADAPROTEIN SA DE C V (MEXICO)
Type
Therapeutic
Approval Details
Approval Id
2e859f0fa96ce185
Drug Name
APO-ENALAPRIL TABLET 20 MG
Product Name
APO-ENALAPRIL TABLET 20 MG
Approval Number
SIN08829P
Approval Date
1996-08-06
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09AA02
Atc Item Name
enalapril
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
ENALAPRIL MALEATE
20 mg
ENALAPRIL MALEATE
20 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 6, 1996
Approval ID
2e859f0fa96ce185
Type
Therapeutic
Back to HSA Approvals